Not applicableStudy completedNCT02547480What this trial is testingLifePearl-Iri Pharmacokinetic StudyWho this might be right forMetastatic Colorectal CancermCRC Terumo Europe N.V. 15
Testing effectiveness (Phase 2)Study completedNCT00083720What this trial is testingErbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to ChemotherapyWho this might be right forColorectal NeoplasmsMetastasesNeoplasm Eli Lilly and Company 87
Testing effectiveness (Phase 2)Looking for participantsNCT06445062What this trial is testingStudy of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid TumorsWho this might be right forColorectal CancerCRCPancreatic Ductal Adenocarcinoma+3 more Revolution Medicines, Inc. 1,130
Testing effectiveness (Phase 2)WithdrawnNCT03307603What this trial is testingYttrium-90 Radioembolization + Nivolumab for Liver + Extra-hepatic Metastases From Colorectal CancerWho this might be right forMetastatic Colorectal Cancer Case Comprehensive Cancer Center
Not applicableLooking for participantsNCT02732860What this trial is testingPersonalized Patient Derived Xenograft (pPDX) Modeling to Test Drug Response in Matching HostWho this might be right forColorectal NeoplasmsColorectal CancerBreast Cancer+3 more University Health Network, Toronto 120
Not applicableUnknownNCT03852290What this trial is testingC677T and A1298C MTHFR Polymorphisms and Fluoropyrimidine Effectiveness in Metastatic Colon CancerWho this might be right forColon CancerMTHFR Gene MutationChemotherapeutic Toxicity+1 more Universidad de Costa Rica 65
Not applicableStudy completedNCT01089413What this trial is testingObservational Study of Bevacizumab [Avastin] in Patients With Metastatic Colorectal Cancer (AVASTART)Who this might be right forColorectal Cancer Hoffmann-La Roche 201
Not applicableActive Not RecruitingNCT03908788What this trial is testingDetection of the Emergence of RAS (Rat Sarcoma Viral Oncogene Homolog) Mutations in Circulating DNA (Deoxyribonucleic Acid) in Patients With mCRC (Metastatic Colorectal Cancer) During Treatment With Anti-EGFR (Epidermal Growth Factor Receptor) TherapyWho this might be right forMetastatic Colorectal Cancer Institut du Cancer de Montpellier - Val d'Aurelle 130
Testing effectiveness (Phase 2)Study completedNCT00460603What this trial is testingStudy With AG-013736 Combined With Chemotherapy And Bevacizumab In Patients With Metastatic Colorectal CancerWho this might be right forColorectal Neoplasms Pfizer 187
Testing effectiveness (Phase 2)Looking for participantsNCT07253896What this trial is testingEfficacy and Safety of AK104 Combined With Chemotherapy and Cetuximab or BevacizumabWho this might be right forSafety Second Affiliated Hospital, Zhejiang University, School of Medicine 40
Testing effectiveness (Phase 2)UnknownNCT00081536What this trial is testingAroplatin and Capecitabine in Patients With Advanced Colorectal Cancer Resistant to Standard TherapiesWho this might be right forColorectal Neoplasms Aronex Pharmaceuticals 105
Testing effectiveness (Phase 2)Study completedNCT04561336What this trial is testingAvelumab Plus Cetuximab in Pre-treated RAS Wild Type Metastatic Colorectal CancerWho this might be right forMetastatic Colorectal CancerRAS Wild Type University of Campania Luigi Vanvitelli 77
Testing effectiveness (Phase 2)Study completedNCT01149304What this trial is testingPreventive Effect of Enoxaparin, Pentoxifylline and Ursodeoxycholic Acid to Radiation Induced Liver ToxicityWho this might be right forColorectal CancerLiver MetastasesIrradiation Damage+1 more University of Magdeburg 22
Testing effectiveness (Phase 2)Study completedNCT02278133What this trial is testingStudy of WNT974 in Combination With LGX818 and Cetuximab in Patients With BRAF-mutant Metastatic Colorectal Cancer (mCRC) and Wnt Pathway MutationsWho this might be right forMetastatic Colorectal Cancer Array BioPharma 20
Early research (Phase 1)Study completedNCT03256344What this trial is testingStudy of Talimogene Laherparepvec With Atezolizumab for Triple Negative Breast Cancer and Colorectal Cancer With Liver MetastasesWho this might be right forMetastatic Triple Negative Breast CancerMetastatic Colorectal Cancer Amgen 36
Testing effectiveness (Phase 2)UnknownNCT01930864What this trial is testingMetformin Plus Irinotecan for Refractory Colorectal CancerWho this might be right forColorectal NeoplasmsAdenocarcinoma Barretos Cancer Hospital 41
Testing effectiveness (Phase 2)Ended earlyNCT02738606What this trial is testingLiver Surgery and Chemotherapy in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery and Lung Metastases That Cannot Be Removed by SurgeryWho this might be right forMetastatic Colorectal CarcinomaMetastatic Malignant Neoplasm in the LiverMetastatic Malignant Neoplasm in the Lung+5 more M.D. Anderson Cancer Center 29
Testing effectiveness (Phase 2)WithdrawnNCT04119830What this trial is testingRintatolimod and Pembrolizumab for the Treatment of Refractory Metastatic or Unresectable Colorectal CancerWho this might be right forMetastatic Colorectal AdenocarcinomaMicrosatellite StableMismatch Repair Proficient+10 more Roswell Park Cancer Institute
Not applicableStudy completedNCT03301493What this trial is testingGenomic Testing and Resulting Medical DecisionsWho this might be right forCancer of Unknown OriginCancer RefractoryCancer of Stomach+12 more Arbeitsgemeinschaft medikamentoese Tumortherapie 1,500
Not applicableStudy completedNCT02167087What this trial is testingSentinel Node Mapping With Indocyanine Green in Colon Cancer: a Feasibility Trial and a Descriptive Serie.Who this might be right forColon CancerLymphatic Metastasis Ismail Gögenür 30